Navigation Links
Spark Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference
Date:12/20/2013

PHILADELPHIA, Dec. 20, 2013 /PRNewswire/ -- Spark Therapeutics, a fully integrated, late-stage gene therapy company, announced today that President and Chief Executive Officer Jeffrey D. Marrazzo will present a company overview at the 32nd Annual J.P. Morgan Healthcare Conference. Marrazzo's presentation will highlight the company's progress in developing potentially curative, one-time gene therapies for the treatment of inherited blindness and hemophilia, and provide an overview of Spark's expertise and capabilities in the clinical development of adeno-associated virus (AAV) vectors.  The presentation will take place at 1:30 PM PT on Tuesday, January 14, 2014 in the Elizabethan C room at the Westin St. Francis in San Francisco, California.

About Spark Therapeutics                                                                                           

Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases. The founding team includes scientists who led the movement to develop gene therapy as a new treatment paradigm, establishing clinical proof of concept in the eye and liver and contributing key insights to the field that have resulted in a resurgence of industry interest in gene-based medicines. Our robust pipeline includes a Phase 3 program in RPE65 blindness and a Phase 1/2 program
'/>"/>

SOURCE Spark Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Snoring Therapy Awarded The Prestigious Spark Award
2. Kalyspo Awarded Best of Ann Arbor SPARK Boot Camp
3. Next Generation Sequencing Bioinformatics Heats up: Nearing $1000 Genome Sparks Soaring Data Output
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  To help health care organizations better ... impact patient care and the bottom line, Novation ... "Innovations in Cardiovascular Devices."  The ... details on promising new technologies that can help ... these options impact the supply chain.   According to ...
(Date:7/24/2014)... , July 24, 2014  Blueprint Medicines (Blueprint), a ... defined cancer patients, today announced the appointment of ... Albers joins Blueprint from Algeta ASA, where he served ... to the acquisition by Bayer. Mr. Albers succeeds ... and Partner at Third Rock Ventures, who will remain ...
(Date:7/24/2014)... 2014  Bayer HealthCare today announced positive results ... 15% foam formulation of its compound azelaic acid ... and pustules of rosacea. An AzA foam formulation ... currently available AzA gel formulation. Papulopustular rosacea is ... pustules) as well as erythema (redness) on the ...
Breaking Medicine Technology:New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 3
... YORK, Nov. 5 Immtech Pharmaceuticals,Inc. (Amex: ... $5.1 million from a,scientific consortium led by the ... received funds from The Bill & Melinda Gates ... African sleeping,sickness (trypanosomiasis) and leishmania. This grant is ...
... experts from the,Alzheimer,s Foundation of America (AFA) today ... in light of research,indicating that cases of mild ... that early diagnosis can lead to appropriate treatment ... chief executive officer, and J. Wesson Ashford,M.D., Ph.D., ...
Cached Medicine Technology:Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 4
(Date:7/24/2014)... and the European Heart Academy (EHA) of the ... announce the launch of a new, executive-style MSc ... cardiovascular sciences. , The MSc in Health Economics, ... equip cardiovascular specialists with the health management, economics, ... advisory, management or leadership roles within the field. ...
(Date:7/24/2014)... devoted to the protein p53 refers to cancer biology, ... suppressor have been described in detail. Furthermore, also in ... metabolic pathways of tumour cells in order to block ... , The most innovative research on p53 attempts to ... and nutrients in healthy cells. Recent studies with cell ...
(Date:7/24/2014)... University of Texas at Arlington professor who co-authored ... foundations engaged in community revitalization has been awarded ... 2014., Maria Martinez-Cosio, associate professor in the School ... award this week at the society,s national conference, ... lecturer and academic coordinator in the Urban Studies ...
(Date:7/24/2014)... parasite becomes resistant to an investigational drug. The ... St. Louis, also is relevant for other infectious ... study appears July 24 in Nature Communications ... causes malaria, make a class of molecules called ... healthy, whether plants, animals or bacteria. In malaria, ...
(Date:7/24/2014)... declaration of contents if you need to know precisely what ... need to be a highly skilled chemist or to have ... the molecular structure of the various substances. Christian Grundahl Frankr, ... he has developed a method that allows him to use ... The ,Fingerprints, of a Substance , The technique is called ...
Breaking Medicine News(10 mins):Health News:LSE and ESC announce the launch of a new executive-style MSc 2Health News:Identified a key molecule in flies that adjusts energy use under starvation conditions 2Health News:Strategy for community development partnerships earns award for UT Arlington professor 2Health News:One route to malaria drug resistance found 2Health News:One route to malaria drug resistance found 3Health News:Chemist develops X-ray vision for quality assurance 2Health News:Chemist develops X-ray vision for quality assurance 3
... LLC Forms Alliance With Veterinary News Network, ... leader in,veterinary hospital captive audience digital signage solutions ... forming one of the,most comprehensive client education systems ... be partnering with emebaVet, bringing interesting,and accurate pet ...
... Children receiving treatment for cancer who are under 2 ... cells called lymphocytes are at,higher risk for severe respiratory ... St. Jude Children,s,Research Hospital investigators and collaborators have ... with respiratory syncytial virus (RSV) while,being treated for cancer ...
... Association Kicks Off National Children,s Dental Health,Month With Outreach ... February is National,Children,s Dental Health Month. It,s sponsored ... awareness among families and policymakers,about the critical importance to ... sixth year in a row, the ADA opened the ...
... the first study to directly compare a contraceptive vaginal ... with the vaginal ring, researchers report in the current ... American College of Obstetricians and Gynecologists. Using the same ... these products became available in 2002 as an alternative ...
... nature cable channels, crocodiles are among natures most fearsome predators. ... weighing 23% of their own body weight. This is analogous ... hamburger weighing 30 pounds. But what to do with all ... quickly, crocodilians risk death from within, or if they are ...
... DIEGO, Feb. 4 Naviscan PET Systems, a privately,held ... the appointment of Paul J. Mirabella as Chairman of ... and CEO, and the,addition of Dr. Abhi Acharya to ... as President and Chief Executive Officer,in July 2007 bringing ...
Cached Medicine News:Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 2Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 3Health News:St. Jude Finds Risk Factors for Severe RSV Infection in Immunocompromised Children 2Health News:St. Jude Finds Risk Factors for Severe RSV Infection in Immunocompromised Children 3Health News:St. Jude Finds Risk Factors for Severe RSV Infection in Immunocompromised Children 4Health News:A Reminder to Parents: Early Dental Visits Essential to Children's Health 2Health News:A Reminder to Parents: Early Dental Visits Essential to Children's Health 3Health News:Ringing endorsement: Women prefer contraceptive ring over patch 2Health News:Gotta have heart! 2Health News:Naviscan Announces a New Chairman and Board Member 2
... throughput reading of entire racks. Its scanner-based image ... and reads in approximately 10 seconds per rack. ... and a list of ActiveX controls is provided ... includes a USB HP Scanner and software. Compatible ...
... with powder-coated steel legs. Height ... in hundreds of sizes and ... light fixtures and ionizing equipment. ... custom building to meet special ...
Round, height-adjustable, steel laboratory stools with small footprint for small spaces • Choose options like different height-adjustment mechanism or paint finish. • your choice of color...
... This BioSafe room is configured specifically ... and chemical analysis. Panels are precision-joined ... easy to wipe down and disinfect. ... double-wall panel design creates strong, rigid ...
Medicine Products: